The company's Evernorth Health Services subsidiary has launched a pharmacy benefit offering that caps monthly copayments for Wegovy and Zepbound, two blockbuster glucagon-like peptide-1 agonists, or GLP-1s, at $200 and counts the spending toward annual deductibles, the company announced in a news release today
Prescription ADHD medications (both stimulant and non-stimulant) have been tested in hundreds of studies involving thousands of patients, with clear evidence of benefit
The delayed gastric emptying caused by semaglutide can lead to feelings of fullness, bloating, and discomfort
Presented for research literature review only Held-Hoelker E et al
Being right once does not make the next forecast correct, but it does make me willing to state the next one clearly enough to be falsifiable
We explain possible causes of semaglutide headaches, and what you can do to prevent and treat them